Skip to main content
    S

    Skye Bioscience, Inc. Common Stock (SKYE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.53
    -0.05 (-3.16%)

    Market Cap: $6.95M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(5/11)
    Avg Surprise
    -5.91%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.12
    Range$-1.12 - $-1.12
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-2.01+44.4%
    60d ago$-2.01+44.4%
    30d ago$-2.01+44.4%
    7d ago$-1.120.0%
    Current$-1.12
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-3.33
    Range$-3.33 - $-3.33
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-3.33---
    Sep 26EST
    		-$-1.12---
    Jun 26
    Reported Aug 14
    		$-0.27$-0.29+6.90%Beat+38.6%
    Mar 26
    Reported May 11
    		$-0.32$-0.32+0.00%Beat-14.3%
    Dec 25
    Reported Mar 10
    		$-2.95$-2.45-20.20%Miss-912.6%
    Sep 25
    Reported Nov 10
    		$-0.32$-0.32+0.00%Beat-220.0%
    Jun 25
    Reported Aug 7
    		$-0.44$-0.34-29.41%Miss-120.0%
    Mar 25
    Reported May 8
    		$-0.28$-0.29+3.45%Beat-55.6%
    Dec 24
    Reported Mar 20
    		$-0.29$-0.28-2.18%Miss+53.8%
    Sep 24
    Reported Nov 7
    		$-0.10N/A+60.00%Beat+96.8%
    Jun 24
    Reported Aug 9
    		$-0.20$-0.19-5.26%Miss-6150.0%
    Mar 24
    Reported May 10
    		$-0.18$-0.16-12.50%Miss-3172.7%
    Dec 23
    Reported Mar 22
    		$-0.63$-0.38-65.79%Miss-6200.0%
    Sep 23
    Reported Nov 13
    		$-3.17$0.00N/AMiss-31555.0%
    Jun 23
    Reported Aug 7
    		$-0.00$0.00N/AMiss+68.0%
    Mar 23
    Reported May 11
    		$-0.01$0.00N/AMiss+45.0%
    Dec 22
    Reported Mar 31
    		$-0.01$0.00N/AMiss+0.0%
    Sep 22
    Reported Nov 14
    		$-0.01$0.00N/AMiss-127.3%
    Jun 22
    Reported Aug 15
    		$-0.01N/AN/ABeat+0.0%
    Mar 22
    Reported May 6
    		$-0.01N/AN/ABeat+0.0%
    Dec 21
    Reported Mar 25
    		$-0.01N/AN/ABeat+0.0%
    Sep 21
    Reported Nov 10
    		$-0.00N/AN/ABeat+56.0%
    Jun 21
    Reported Aug 6
    		$-0.01N/AN/ABeat+0.0%
    Mar 21
    Reported May 7
    		$-0.01N/AN/ABeat+0.0%
    Dec 20
    Reported Mar 1
    		$-0.01N/AN/ABeat-133.3%
    Sep 20
    Reported Nov 6
    		$-0.01N/AN/ABeat+75.0%
    Jun 20
    Reported Aug 13
    		$-0.01$0.00N/AMiss-112.5%
    Mar 20
    Reported May 8
    		$-0.01$0.00N/AMiss+90.9%
    Dec 19
    Reported Mar 20
    		$0.03$0.00N/ABeat+160.0%
    Sep 19
    Reported Nov 13
    		$-0.04$0.00N/AMiss-100.0%
    Jun 19
    Reported Aug 9
    		$0.08$0.00N/ABeat+500.0%
    Mar 19
    Reported May 9
    		$-0.11$0.00N/AMiss-22.2%
    Dec 18
    Reported Mar 14
    		$-0.05$0.00N/AMiss-66.7%
    Sep 18
    Reported Nov 13
    		$-0.02$0.00N/AMiss+0.0%
    Jun 18
    Reported Aug 10
    		$-0.02$0.00N/AMiss+0.0%
    Mar 18
    Reported May 15
    		$-0.09$0.00N/AMiss-262.9%
    Dec 17
    Reported Mar 19
    		$-0.03$0.00N/AMiss+66.7%
    Sep 17
    Reported Nov 14
    		$-0.02$0.00N/AMiss-
    Jun 17
    Reported Aug 11
    		$-0.02$0.00N/AMiss-
    Mar 17
    Reported May 12
    		$-0.02$0.00N/AMiss-
    Dec 16
    Reported Mar 10
    		$-0.09$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.05EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-233.90%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.95xQuick Ratio0.95x
    Trading Statistics
    Beta2.86Avg Volume59.44K
    52-Week High$2.2552-Week Low$0.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.64
    SMA 20$1.66
    SMA 50$2.32
    SMA 200$5.24
    EMA 10$1.64
    EMA 20$1.74
    EMA 50$2.43
    EMA 200$5.98

    MACD

    Line: -0.20Signal: -0.25Hist: 0.05

    ADX

    ADX: 20.9+DI: 9.3-DI: 8.7

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$1.30

    Bollinger Bands

    Upper Band$1.81
    Lower Band$1.52
    %B Position1778%(Upper)
    Band Width0.05

    RSI (14-Day)

    Neutral
    34.3

    Momentum Oscillators

    Stoch %K19.4
    Stoch %D27.4
    Williams %R-91.8
    ROC (10d)-3.8%
    Momentum-0.06
    CCI (20d)-131.2
    MFI (14d)37.6

    Volatility Measures

    ATR (14d)$0.41(26.6%)
    StdDev (20d)0.07
    Hist Vol101.7%(High)

    Volume Flow

    VWAP$1.56
    OBV7.8M
    AD Line23.0B
    CMF (20d)-0.239

    Volume Metrics

    Avg Vol (20d)60.8K
    Vol Ratio0.5x(Low)
    VWMA (20d)$1.69

    Pivot Points

    R3$1.82
    R2$1.76
    R1$1.67
    Pivot Point$1.61
    S1$1.52
    S2$1.46
    S3$1.37

    Advanced Oscillators

    TSI-28.72
    Ultimate Osc33.2
    KST-213.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$163,389$0
    Cost of RevenueN/A$172,886$180,009N/A$187,066$177,379$175,293$65,997$29,790$27,560$28,371$28,789
    Gross ProfitN/A$-172,886$-180,009N/A$-187,066$-177,379$-175,293$-65,997$-29,790$-27,560$-28,371$-28,789
    Operating Expenses$11.06M$12.50M$14.90M$13.26M$18.24M$11.76M$10.67M$4.97M$8.41M$6.15M$4.09M$24.71M
    R&D$3.94M$7.76M$11.47M$9.36M$14.34M$7.20M$7.79M$4.88M$4.08M$1.95M$1.59M$1.25M
    SG&A$3.87M$4.74M$3.43M$3.91M$3.91M$4.56M$4.55M$4.64M$4.33M$4.21M$2.49M$2.24M
    Operating Income$-11,061,303$-12,674,366$-14,895,544$-13,264,534$-18,243,925$-11,759,562$-10,666,101$-4,968,796$-8,405,571$-6,152,250$-4,086,257$-24,705,766
    Interest Income$103,208$169,615$274,096$418,474$533,090$619,054$732,273$1.29M$961,237$426,514$50,305$39,882
    Interest Expense$3,299$2,199$0$0$0$1,452$428,748$291,068$450,052$436,936$430,135$271,307
    Income Before Tax$-10,783,194$-12,509,361$-14,441,963$-12,754,660$-17,621,472$-11,101,319$-9,746,479$-3,898,297$-7,894,745$-5,017,531$-4,419,930$-24,945,834
    Income Tax Expense$3,400$0$0$0$3,400$2,000$0$0$8,071$2,000$-982,006$291,814
    Net Income$-10,786,594$-12,509,361$-14,441,963$-12,754,660$-17,624,872$-11,103,319$-9,746,479$-3,898,297$-7,902,816$-5,019,531$-4,419,930$-24,945,834
    EBITDA$-10,622,297$-12,334,276$-14,261,954$-12,575,762$-17,434,406$-10,922,488$-9,618,101$-3,541,232$-7,414,903$-4,553,035$-3,961,424$-24,625,231
    EBIT$-10,779,895$-12,507,162$-14,441,963$-12,754,660$-17,621,472$-11,099,867$-9,793,394$-3,607,229$-7,444,693$-4,580,595$-3,989,795$-24,654,020
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SKYE

    News

    TANG CAPITAL MANAGEMENT LLC Acquires 263,560 Shares of Skye Bioscience Inc (SKYE)

    TANG CAPITAL MANAGEMENT LLC has acquired 263,560 shares of Skye Bioscience Inc (SKYE) at $1.65 per share, establishing a new position that represents 0.02% of the firm's portfolio and 6.00% of SKYE's outstanding shares....

    GuruFocus•10/15/26•Somewhat-Bullish

    Two holders report shared voting power over the same 263,560 Skye Bioscience (SKYE) shares.

    Tang Capital Management, LLC and Kevin Tang have each reported beneficial ownership of 263,560 shares of Skye Bioscience (SKYE) common stock, representing a 6.0% stake. Both entities...

    Stock Titan•10/14/26•Neutral

    Pretax income of Skye Bioscience, Inc. – DUS:09R0

    This page from TradingView provides financial information for Skye Bioscience, Inc. (DUS:09R0) listed on the Dusseldorf Stock Exchange. It specifically highlights the pretax income for the company...

    TradingView•10/12/26•Neutral

    Diluted net income available to common stockholders of Skye Bioscience, Inc. – DUS:09R0

    This article states the diluted net income available to common stockholders of Skye Bioscience, Inc., trading under the symbol DUS:09R0 on the Dusseldorf Stock Exchange. It appears to be a financial data point presented...

    TradingView•10/12/26•Neutral

    Skye Bioscience Inc Share Price - SKYE, RNS News, Articles, Quotes, & Charts (NASDAQ: SKYE)

    This page provides financial information for Skye Bioscience Inc (NASDAQ: SKYE), including its current share price, market cap...

    Proactive financial news•10/6/26•Somewhat-Bullish

    SKYE Valuation and Fair Value

    P/E
    -0.0x
    P/B
    -15.3x
    See GNG's fair value

    SKYE Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -233.9%

    SKYE Competitors

    CompanyTicker
    Predictive Oncology IncPOAI
    FibroBiologics, Inc. Common StockFBLG
    InMed Pharmaceuticals IncINM
    Nutriband Inc. WarrantNTRBW
    XWELL Inc.XWEL
    Neurosense Therapeutics LtdNRSN
    Soligenix Inc.SNGX
    Co-Diagnostics, Inc. Common StockCODX

    Sector: Healthcare

    SKYE Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    2
    Hold
    2
    Sell
    0
    Strong Sell
    0

    SKYE Bull Case vs Bear Case

    Bull case

    • 60.0% of SKYE's analyst ratings are Buy or Strong Buy.

    Bear case

    • SKYE beat EPS estimates in 37.5% of its last 8 reported quarters.

    SKYE Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    2.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.12
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About SKYE

    Does SKYE pay dividends?

    Skye Bioscience, Inc. Common Stock (SKYE) does not currently pay a regular dividend.

    What is SKYE's market cap?

    Skye Bioscience, Inc. Common Stock (SKYE) has a market capitalization of $6.95M with a current stock price of $1.53.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In